Xeris Biopharma Holdings, Inc. Common Stock (XERS) is a publicly traded Healthcare sector company. As of July 23, 2026, XERS trades at $8.24 with a market cap of $1.52B and a P/E ratio of 0.00. XERS moved -1.91% today. Year to date, XERS is +6.75%; over the trailing twelve months it is +63.67%. Its 52-week range spans $3.14 to $10.08. Analyst consensus is strong buy with an average price target of $12.25. Rallies surfaces XERS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for XERS shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $8.24 |
| Market Cap | $1.52B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.08 |
| 52-Week Low | $3.14 |
| Volume | 192.19K |
| Avg Volume | 0 |
| Revenue (TTM) | $33.38M |
| Net Income | $-83.78M |
| Gross Margin | 66.73% |
4 analysts cover XERS: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $12.25.